NEW YORK (360Dx) – Immunovia today announced it has signed a research collaboration deal with Linköping University to discover autoimmine disease diagnostic biomarkers.

The deal with the university's faculty of medicine and health sciences aims to accelerate the development of new diagnostic tests using Immunovia's Immray antibody array platform. Specifically, it targets rheumatoid arthritis, primary Sjögren’s syndrome, systemic lupus erythematosus (SLE), and vasculitis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.